STAA - STAAR Surgical: Keeping An Eye On The Shares
2024-06-13 06:36:02 ET
Summary
- STAAR Surgical saw steady growth in business and market share, driven by the EVO ICL Lens, an alternative solution for nearsightedness.
- The company outlined ambitious three-year plans for significant revenue growth.
- Shares experienced significant volatility this spring, while underlying growth has been lackluster, leaving me somewhat puzzled here.
- I like the long-term potential and promise of the business, but require some real execution here to have conviction.
In the final days of 2023, I concluded that shares of STAAR Surgical ( STAA ) were slowly coming in my sight. The manufacturer of the EVO ICL Lens, the clear vision solution for nearsightedness which does not require contact lenses or glasses, has seen steady growth in the business and its market share....
STAAR Surgical: Keeping An Eye On The Shares